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This horizon scanning article explores the complexities 
involved in international medical travel, whereby 
patients travel abroad to receive required health care, 
and as a consequence, the possibilities for integrated 
global health policies.
The pieces compiled in this report collectively imply 
that the organisations working in health issues can 
no longer be considered as belonging to one distinct 
sector or another. Previously, it may have been 
sufficient to conclude research by suggesting the 
need for better interdisciplinary efforts in improving 
health services or to highlight a group’s particular skill 
in working between private companies, universities 
and government bodies. However, as economic 
pressures demand that investment in health care 
be more effective, sustainable, and replicable, such 
collaborative work is now a must. There is perhaps 
no better example of this than the increase in 
international medical travel and its implications for 
global health.
The basics
Medical travel refers to situations where patients 
leave their home country and travel to another for the 
primary purposes of receiving necessary care. This is 
distinct from medical tourism, which typically occurs 
for cosmetic or other elective procedures. Conducting 
research on medical travel is extremely difficult 
because the data is hard to ascertain: many instances 
of medical travel occur outside of any structured 
programmes or legal arrangements. Additionally, 
although much of Europe has standing arrangements 
for reciprocal care for citizens while abroad, these were 
primarily established to help people who experience 
medical emergencies while already travelling, not to 
support a chronic or otherwise non-emergency care 
need. 
Not just for doctors and legislators
Travel for medical care is rapidly expanding, and 
there is little doubt this trend will continue .  Major 
international organisations such as the OECD have 
further indicated that medical travel may have the 
potential to attenuate 
the rise in health care 
costs while increasing 
access .  Yet there is a 
clear lack of evidence 
on what is referred to 
as Global Health Access 
Policy (GHAP)   to address 
the multitude of political, 
medical, and ethical 
issues. The questions 
involved in establishing 
programmes whereby 
patients can travel 
between countries to 
receive care are not simply 
ones of logistics, nor are 
they only to be discussed 
among clinicians 
providing care or 
bureaucrats determining 
relevant legislation. In 
order to ensure the most 
responsible development 
of innovative policies that 
maximise the potential of 
increased access without 
creating harm, an all-
hands (e.g. all possible 
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stakeholders) approach to GHAPs is a necessity. Given 
the projected increase in medical travel, it is also 
urgent.
What we’re doing at Cambridge: getting junior 
researchers involved in evidence-based policy
GHAP research is highly complicated; it requires 
numerous aspects to be taken into account, including: 
clinical considerations, patient considerations, legal 
frameworks, economic models, travel and logistical 
data, patient safety and the health care industry – to 
name only a few. Although some programmes may 
already be in place, most are only established for a 
limited number of countries and have little potential 
to reach a global population. Therefore, international 
quality standards are needed to determine possibility 
for wider involvement.
To address such complex topics, we have engaged 
early career researchers from the Junior Researcher 
Programme (JRP) to compile a multitude of 
interdisciplinary, interrelated projects. The JRP is 
an ideal team for this undertaking because such 
work requires a great deal of focused effort from a 
committed and diverse consortium that is strong 
in numbers. Furthermore, by using such a globally 
representative group, we have the ability to scour an 
extremely broad literature base and thereby consider 
a broad range of solutions to the many issues faced. 
Ongoing projects include:
(a) Extensive reviewing across a range of academic, 
institutional and policy sources on existing medical 
travel programmes
(b) Developing guidance on international quality 
standards for high-volume procedures
(c) Patient and clinician decision-making related to 
travelling for care
(d) Developing legal frameworks for medical travellers 
as to ensure increased travel does not increase costs 
for locals
(e) Identifying potential leaders for medical travel 
programmes, such as insurance companies, health 
ministries and the travel industry
The future of the GHAP project: well-being
Like all areas of health and health care, work on 
medical travel must consider the implications for 
well-being. While some may believe that going abroad 
to receive care without the benefit of social support 
is not a practical solution to low access to care, 
the alternative of receiving no care is surely worse. 
For this reason, once the aspects above have been 
addressed by our collaborative, our long-term aim is 
to look at how to ensure the well-being of medical 
travellers using a scientific approach. As with our 
previous work, we will endeavour to include the many 
possible stakeholders involved the care of patients: 
clinicians, policymakers, employers, family members, 
support services and the patients themselves. By such 
means, we can ensure a responsible approach to an 
innovative, yet controversial, possibility for global 
health policies.
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